We characterized subpopulations of CD4+ T cells in PBMCs, and found increased regulatory T cell (CD4+ CD25+ Foxp3+) percentages in ALS patients’ PBMCs (Figure 8a,d). Here, CD4 is linked to amyotrophic lateral sclerosis.